89 related articles for article (PubMed ID: 24077328)
21. Dystroglycan Depletion Impairs Actin-Dependent Functions of Differentiated Kasumi-1 Cells.
Escárcega-Tame MA; Martínez-Vieyra I; Alonso-Rangel L; Cisneros B; Winder SJ; Cerecedo D
PLoS One; 2015; 10(12):e0144078. PubMed ID: 26630171
[TBL] [Abstract][Full Text] [Related]
22. Dasatinib as a treatment for Duchenne muscular dystrophy.
Lipscomb L; Piggott RW; Emmerson T; Winder SJ
Hum Mol Genet; 2016 Jan; 25(2):266-74. PubMed ID: 26604135
[TBL] [Abstract][Full Text] [Related]
23. Novel Nuclear Protein Complexes of Dystrophin 71 Isoforms in Rat Cultured Hippocampal GABAergic and Glutamatergic Neurons.
Rodríguez-Muñoz R; Cárdenas-Aguayo Mdel C; Alemán V; Osorio B; Chávez-González O; Rendon A; Martínez-Rojas D; Meraz-Ríos MA
PLoS One; 2015; 10(9):e0137328. PubMed ID: 26378780
[TBL] [Abstract][Full Text] [Related]
24. Nuclear import of β-dystroglycan is facilitated by ezrin-mediated cytoskeleton reorganization.
Vásquez-Limeta A; Wagstaff KM; Ortega A; Crouch DH; Jans DA; Cisneros B
PLoS One; 2014; 9(3):e90629. PubMed ID: 24599031
[TBL] [Abstract][Full Text] [Related]
25. Nuclear targeting of dystroglycan promotes the expression of androgen regulated transcription factors in prostate cancer.
Mathew G; Mitchell A; Down JM; Jacobs LA; Hamdy FC; Eaton C; Rosario DJ; Cross SS; Winder SJ
Sci Rep; 2013 Sep; 3():2792. PubMed ID: 24077328
[TBL] [Abstract][Full Text] [Related]
26. γ-Secretase Dependent Nuclear Targeting of Dystroglycan.
Leocadio D; Mitchell A; Winder SJ
J Cell Biochem; 2016 Sep; 117(9):2149-57. PubMed ID: 26990187
[TBL] [Abstract][Full Text] [Related]
27. Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.
Mahajan NP; Liu Y; Majumder S; Warren MR; Parker CE; Mohler JL; Earp HS; Whang YE
Proc Natl Acad Sci U S A; 2007 May; 104(20):8438-43. PubMed ID: 17494760
[TBL] [Abstract][Full Text] [Related]
28. RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.
Schmidt LJ; Duncan K; Yadav N; Regan KM; Verone AR; Lohse CM; Pop EA; Attwood K; Wilding G; Mohler JL; Sebo TJ; Tindall DJ; Heemers HV
Mol Endocrinol; 2012 May; 26(5):716-35. PubMed ID: 22456196
[TBL] [Abstract][Full Text] [Related]
29. Dystroglycan expression is reduced during prostate tumorigenesis and is regulated by androgens in prostate cancer cells.
Sgambato A; De Paola B; Migaldi M; Di Salvatore M; Rettino A; Rossi G; Faraglia B; Boninsegna A; Maiorana A; Cittadini A
J Cell Physiol; 2007 Nov; 213(2):528-39. PubMed ID: 17516554
[TBL] [Abstract][Full Text] [Related]
30. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
[TBL] [Abstract][Full Text] [Related]
31. Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer.
Esser AK; Miller MR; Huang Q; Meier MM; Beltran-Valero de Bernabé D; Stipp CS; Campbell KP; Lynch CF; Smith BJ; Cohen MB; Henry MD
J Biol Chem; 2013 Jan; 288(4):2132-42. PubMed ID: 23223448
[TBL] [Abstract][Full Text] [Related]
32. A role for β-dystroglycan in the organization and structure of the nucleus in myoblasts.
Martínez-Vieyra IA; Vásquez-Limeta A; González-Ramírez R; Morales-Lázaro SL; Mondragón M; Mondragón R; Ortega A; Winder SJ; Cisneros B
Biochim Biophys Acta; 2013 Mar; 1833(3):698-711. PubMed ID: 23220011
[TBL] [Abstract][Full Text] [Related]
33. PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees.
Mi H; Muruganujan A; Thomas PD
Nucleic Acids Res; 2013 Jan; 41(Database issue):D377-86. PubMed ID: 23193289
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
